1. Home
  2. CAE vs ROIV Comparison

CAE vs ROIV Comparison

Compare CAE & ROIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CAE Inc.

CAE

CAE Inc.

N/A

Current Price

$24.08

Market Cap

7.7B

Sector

N/A

ML Signal

N/A

Logo Roivant Sciences Ltd.

ROIV

Roivant Sciences Ltd.

N/A

Current Price

$35.74

Market Cap

28.7B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CAE
ROIV
Founded
1947
2014
Country
Canada
United Kingdom
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.7B
28.7B
IPO Year
2002
2021

Fundamental Metrics

Financial Performance
Metric
CAE
ROIV
Price
$24.08
$35.74
Analyst Decision
Buy
Strong Buy
Analyst Count
14
13
Target Price
$29.93
★ $48.08
AVG Volume (30 Days)
780.5K
★ 6.9M
Earning Date
11-10-2026
11-09-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $8,260,000.00
Revenue This Year
$1.98
$530.75
Revenue Next Year
$1.84
$685.92
P/E Ratio
$35.13
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$22.76
$15.25
52 Week High
$34.24
$42.50

Technical Indicators

Market Signals
Indicator
CAE
ROIV
Relative Strength Index (RSI) 45.16 46.25
Support Level $23.99 $33.15
Resistance Level $27.11 $37.59
Average True Range (ATR) 0.57 1.21
MACD 0.05 -0.40
Stochastic Oscillator 34.56 22.31

Price Performance

Historical Comparison
CAE
ROIV

About CAE CAE Inc.

CAE Inc provides training and aviation services, integrated enterprise solutions, in-service support, and crew-sourcing services. The company operations are managed through two segments: i) Civil Aviation: Provides comprehensive training solutions for flight, cabin, maintenance, ground personnel and air traffic controllers in commercial, business and helicopter aviation, a complete range of flight simulation training devices, ab initio pilot training and crew sourcing services, as well as airline operations digital solutions; and ii) Defense and Security which is a world-wide training and simulation provider delivering scalable, platform-independent solutions that enable and enhance force readiness and security. It generates the majority of its revenue from the Civil Aviation segment.

About ROIV Roivant Sciences Ltd.

Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.

Share on Social Networks: